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β-adrenergic receptor (β-AR) blockers may be administered during acute myocardial
infarction (MI), as they reduce energy demand through negative chronotropic and
inotropic effects and prevent ischemia-induced arrhythmogenesis. However, the direct
effects of β-AR blockers on ventricular electrophysiology and intracellular Ca2+ handling
during ischemia remain unknown. Using optical mapping of transmembrane potential
(with RH237) and sarcoplasmic reticulum (SR) Ca2+ (with the low-affinity indicator
Fluo-5N AM), the effects of 15 min of regional ischemia were assessed in isolated rabbit
hearts (n = 19). The impact of β-AR inhibition on isolated hearts was assessed by
pre-treatment with 100 nM propranolol (Prop) prior to ischemia (n = 7). To control for
chronotropy and inotropy, hearts were continuously paced at 3.3 Hz and contraction
was inhibited with 20 µM blebbistatin. Untreated ischemic hearts displayed prototypical
shortening of action potential duration (APD80) in the ischemic zone (IZ) compared to
the non-ischemic zone (NI) at 10 and 15 min ischemia, whereas APD shortening was
prevented with Prop. Untreated ischemic hearts also displayed significant changes in
SR Ca2+ handling in the IZ, including prolongation of SR Ca2+ reuptake and SR Ca2+
alternans, which were prevented with Prop pre-treatment. At 5 min ischemia, Prop pre-
treated hearts also showed larger SR Ca2+ release amplitude in the IZ compared to
untreated hearts. These results suggest that even when controlling for chronotropic and
inotropic effects, β-AR inhibition has a favorable effect during acute regional ischemia via
direct effects on APD and Ca2+ handling.
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INTRODUCTION
Ventricular arrhythmias during the acute phase of myocardial infarction (MI) remain a leading
cause of death (Henriques et al., 2005; Benjamin et al., 2017). Experimental studies indicate that
ventricular arrhythmias peak between ∼10 and 30 min of myocardial ischemia (Curtis, 1998; de
Groot and Coronel, 2004; Di Diego and Antzelevitch, 2011). Ischemia-induced arrhythmias are
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multi-factorial and can be attributed to several changes in
myocyte electrophysiology, including intracellular Ca2+
overload, extracellular K+ accumulation, slow conduction,
shortening of the action potential duration (APD), increased
dispersion of repolarization, and post-repolarization
refractoriness (Akar and Akar, 2007; Di Diego and Antzelevitch,
2011; Coronel et al., 2012).
β-adrenergic receptor (β-AR) blockers have been shown to
reduce ventricular arrhythmias during the acute phase of MI
(Norris et al., 1984). β-AR blockers also limit infarct size, relieve
pain, and reduce early mortality when administered during
acute MI (López-Sendón et al., 2004). Recent evidence suggests
that when administered prior to primary percutaneous coronary
intervention (PCI), intravenous β-AR blocker therapy results
in improved ejection fraction and fewer major adverse cardiac
events compared to PCI without β-AR blocker pre-treatment
(Halkin et al., 2004; Pizarro et al., 2014). The mechanisms
underlying these improved outcomes are likely multi-factorial,
but may stem in part from a global reduction in oxygen demand
due to reductions in heart rate and contractility, as well as
inhibition of β-AR signaling in the ischemic region.
Indeed, β-AR activation may be locally elevated in the
ischemic region due to release of catecholamines from the
ischemic cardiac sympathetic nerves (Schömig et al., 1984, 1987;
Lameris et al., 2000; Killingsworth et al., 2004). This local, non-
exocytotic catecholamine release is in response to intracellular
acidification of the neurons and is independent of central
sympathetic drive (i.e., occurs in vivo as well as in in vitro
isolated ischemic hearts) (Schömig et al., 1987). Some studies
indicate that the local norepinephrine (NE) concentration in
the extracellular space can rise to as much as 100- to 1,000-
fold higher than normal plasma concentrations within 10–
30 min of no-flow ischemia or anoxia (Schömig et al., 1987;
Kurz et al., 1995; Lameris et al., 2000). Significant elevation
of interstitial NE has also been observed following several
minutes of fibrillation-induced global ischemia (Killingsworth
et al., 2004). Although less pronounced, myocardial interstitial
levels of dopamine (DA, precursor to NE) and epinephrine
(Epi) also rise significantly during ischemia (Schömig et al.,
1984; Lameris et al., 2000). Thus, locally enhanced β-AR
stimulation may exacerbate the arrhythmogenic effects of
ischemia by contributing to Ca2+ overload and additional
APD shortening due to β-AR augmentation of repolarizing K+
currents.
The goal of the present study was to determine the direct
impact of β-AR inhibition on ventricular electrophysiology and
sarcoplasmic reticulum (SR) Ca2+ handling in the ischemic
myocardium. To accomplish this, we performed dual optical
mapping of transmembrane potential (Vm) and SR Ca2+ in
Abbreviations: ADP, adenosine diphosphate; APD, action potential duration;
ATP, adenosine triphosphate; β-AR, β-adrenergic receptor; BZ, border zone; ECG,
electrocardiogram; IZ, ischemic zone; LCA, left circumflex artery; MI, myocardial
infarction; NE, norepinephrine; NET, norepinephrine transporter; NI, non-
ischemic zone; PCI, percutaneous coronary intervention; PCL, pacing cycle length;
Prop, propranolol; RyR, ryanodine receptor; SERCA, sarcoplasmic reticulum
Ca2+-ATPase; SR, sarcoplasmic reticulum; Vm, transmembrane potential.
isolated rabbit hearts. Using a low-affinity Ca2+ indicator (Fluo-
5N AM, Kd ≈ 400 µM), free intra-SR Ca
2+ can be directly
monitored everywhere on the surface of the heart (Wang et al.,
2014, 2015). Thus, SR Ca2+ release represents a rapid decrease
in the signal (the inverse of the intracellular Ca2+ transient) and
SR Ca2+ ATPase (SERCA) function can be directly assessed via
the time constant of SR Ca2+ reuptake. Acute regional ischemia
was induced by ligation of the left circumflex artery (LCA).
To isolate electrophysiological effects from metabolic effects
that may be secondary to negative chronotropy and inotropy
induced by β-AR inhibition, hearts were continuously paced
and contraction was abolished with the excitation-contraction
uncoupler blebbistatin.
METHODS
Ethical Approval
All procedures involving animals were approved by the Animal
Care and Use Committee of the University of California, Davis
and adhered to the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1996).
Langendorff Perfusion
Male New Zealand White rabbits (n = 19) weighing 3–3.5 kg
were anesthetized with a single intravenous injection of
pentobarbital sodium (50 mg/kg) containing 1000 IU heparin.
Hearts were rapidly removed and perfused as previously
described (Wang et al., 2014). Briefly, following cannulation of
the aorta, Langendorff perfusion was initiated with oxygenated
(95% O2, 5% CO2) modified Tyrode’s solution of the following
composition (in mmol/L): NaCl 128.2, CaCl2 1.3, KCl 4.7, MgCl2
1.05, NaH2PO4 1.19, NaHCO3 20, and glucose 11.1 (pH 7.4 ±
0.05). Flow rate (25–35 mL/min) was adjusted to maintain a
perfusion pressure of 60–70mmHg. TwoAg/AgCl disc electrodes
were positioned in the bath to record an electrocardiogram
(ECG) analogous to a lead I configuration. A bipolar pacing
electrode was positioned on the base of the right ventricular
epicardium for pacing, which was performed at a pacing cycle
length (PCL) of 300 ms using a 2 ms pulse at twice the diastolic
threshold.
Dual Optical Mapping of SR Ca2+ and Vm
Optical mapping of Vm and intra-SR free [Ca2+] ([Ca2+]SR)
was performed as previously described (Wang et al., 2014,
2015). After stabilization of perfusion (∼10 min), the excitation-
contraction uncoupler blebbistatin (Tocris Bioscience, Ellisville,
MO; 10–20 µM) was added to the perfusate. Hearts were then
switched to a recirculating perfusate (200 mL) containing 5
µM Fluo-5N AM [Invitrogen, Carlsbad, CA; initially dissolved
in 0.25 mL dimethyl sulfoxide (DMSO) and 0.25 mL 20%
pluronic acid for a final concentration of 0.25 and 0.025%,
respectively during the dye loading] for 60 min at room
temperature, followed by a 15 min washout at 37◦C. A
lead I ECG was continuously monitored throughout the
loading procedure. Hearts were subsequently stained with the
voltage-sensitive dye RH237 (Invitrogen, Carlsbad, CA; 50
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µl of 1 mg/ml in DMSO). All experiments were performed
at 37◦C.
The anterior epicardial surface was excited using LED light
sources centered at 470 nm (Mightex, Pleasanton, CA) and
bandpass filtered from 475 to 495 nm (Semrock, Rochester,
NY). The emitted fluorescence was collected through a THT
macroscope (SciMedia, Costa Mesa, CA) and split with a
dichroic mirror at 593 nm (Semrock, Rochester, NY). The longer
wavelength moiety, containing the Vm signal, was longpass
filtered at 715 nm and the shorter wavelength moiety, containing
the [Ca2+]SR signal, was bandpass filtered with a 28 nm filter
centered at 520 nm (Semrock, Rochester, NY). The emitted
fluorescence signals were recorded using two CMOS cameras
(MiCam Ultima-L, SciMedia, Costa Mesa, CA) with a sampling
rate of 0.5–1 k Hz, and 100× 100 pixels with a 31× 31 mm field
of view.
Experimental Protocol
Epicardial pacing at a PCL of 300 ms (3.3 Hz) was continuously
maintained throughout the experiment except for brief instances
at baseline, 15 min ischemia, and 15 min reperfusion, when
pacing at PCL = 250 ms was performed to evoke alternans.
Baseline electrophysiological parameters were measured at the
beginning of the experiment and again 10 min later to assure
stability of the experimental preparation. Time= 0 in subsequent
plots represents the immediate pre-ischemic time point. The
obtuse marginal branch of the LCA was then identified and
ligated around a small piece of tubing (Figure 1A). A lead I
ECG was continuously monitored and ligation was confirmed
by ST segment elevation. Ischemia was maintained for 15 min
during which optical files were recorded at 2, 5, 10, and 15 min.
The tube within the ligature was then removed to allow for
reperfusion and data were again collected at 2, 5, 10, and 15 min
of reperfusion. A subset of hearts (n= 7) were randomly assigned
to acute pre-treatment with the non-specific β-AR blocker,
propranolol (Prop, 100 nM). A non-specific β-AR blocker was
chosen because of the potentially high levels of local DA and Epi,
which may activate β2- in addition to the β1-ARs activated by
high local NE. Prop was added to the perfusate following the first
set of baseline measurements and maintained in the perfusate
throughout ischemia and reperfusion. The effect of Prop was
assessed 10 min after addition and did not significantly impact
FIGURE 1 | (A) Photograph of Langendorff-perfused rabbit heart showing ligation site (red arrow). Following mapping, the ligature was re-tightened and hearts were
perfused with Evan’s blue dye to demarcate the non-ischemic (NI), ischemic zone (IZ), and border zone (BZ). Dashed area near the ligation site was not included in
optical data analysis. (B,C) APD80 and SR Ca
2+ transient duration (SRCaTD80) at baseline (beginning of experiment) and after 10 min (pre-ischemic time point) to
assure stability of the experimental preparation prior to ischemia. Prop-treated hearts received drug (100 nM) immediately following baseline recordings. (D,E)
Representative ECGs at preischemia, 15 min ischemia, and following 15 min reperfusion in a control (D) and Prop-treated heart (E). Prominent ST segment elevation
is observed during ischemia in control hearts (red arrow, D) and resolves following reperfusion, whereas only minor ST elevation is observed in Prop-treated hearts (red
arrow, E) despite confirmed perfusion defects with Evan’s blue staining. (F) Mean ST segment elevation (normalized to QRS amplitude) at 15 min ischemia.
Mean±SD. N = 4–5 (p<0.05: * vs. Control).
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either Vm or SR Ca2+ properties (Figures 1B,C, SR Ca2+ tau
before vs. after Prop: 55.5± 3.3 vs. 58.3± 3.1 ms, p= NS).
Following mapping, the tube was re-inserted through the
ligature to reproduce ischemia and Evan’s blue dye was injected
to demarcate the ischemic region (Figure 1A). This visual
demarcation allowed us to define precise areas for analysis that
were in the non-ischemic (NI) zone, ischemic zone (IZ), and
border zone (BZ: area on the border between NI and IZ). Areas
directly adjacent and underneath the tubing were excluded from
analysis (Figure 1A, shaded region).
Data Analysis
Relative ST segment elevation on the volume-conducted ECG
was quantified as the ratio of the maximal ST amplitude to
the QRS amplitude. Optical mapping data were analyzed with
two commercially available analysis programs (BV_Analyze,
Brainvision, Tokyo, Japan; and Optiq, Cairn, UK). Vm and
[Ca2+]SR datasets were spatially aligned and processed with a
Gaussian spatial filter (radius 3 pixels). For both action potentials
(APs) and SR Ca2+ transients, activation time was determined
at 50% of the maximal (or minimal for SR Ca2+) amplitude.
APD and SR Ca2+ transient durations were calculated at 80%
return to baseline. SR Ca2+ transient amplitude was defined
as systolic–diastolic fluorescence and this value was normalized
to the pre-ischemic amplitude since these measurements are
uncalibrated and only reflect relative changes in [Ca2+]SR.
SERCA function was assessed using the time constant (τ) of a
single exponential fit to the recovery portion of the SR Ca2+
trace (from 5 to 90% recovery). The spectral method was used
to quantify the magnitude and spatial extent of APD and SR
Ca2+ alternans as previously described (Wang et al., 2014). For
APD, SR Ca2+ duration, SR Ca2+ amplitude, and SR Ca2+
diastolic fluorescence (reflective of uncalibrated relative changes
in diastolic [Ca2+]SR), data were normalized to pre-ischemic
(Time= 0) values.
Statistics
Data are expressed as mean ± standard deviation (SD) and
were compared using a two-way ANOVA with Tukey’s multiple
comparison post-testing. P < 0.05 was considered statistically
significant. Statistics were performed in GraphPad Prism 7.
RESULTS
β-AR Inhibition Prevents Ischemia-Induced
APD Shortening
Prior to assessing the impact of ischemia and β-AR inhibition
on electrophysiology and SR Ca2+ handling, stability of the
experimental preparation was evaluated. Measurements of
APD80 and SR Ca2+ transient duration (SRCaTD80) were
identical at baseline (beginning of experiment) and 10 min later
(pre-ischemic) (Figures 1B,C). To assess the effects of β-AR
inhibition on APD shortening during ischemia, maps of APD80
were created and data compared from the NI, IZ, and BZ
of control and Prop-pretreated hearts. As expected, regional
ischemia produced rapid shortening of APD80 in the IZ, and
to a lesser extent in the BZ, of control hearts (Figures 2A,C,E).
There was a gradual, non-significant prolongation of APD80 in
the NI of control hearts throughout ischemia and reperfusion
(Figure 2E). In contrast, Prop pre-treatment led to only minor,
non-significant shortening of APD80 in the IZ and BZ during
ischemia (Figures 2B,D), despite confirmed perfusion defects
when Evan’s blue dye was injected. There were no statistical
differences in APD80 observed between the IZ, BZ, and NI zones
at any time point in Prop-treated hearts (Figure 2F). Consistent
with these findings, ST segment elevation was significantly
higher in control vs. Prop pre-treated hearts at 15 min ischemia
(Figures 1D–F).
β-AR Inhibition Increases SR Ca2+ Release
during Early Ischemia Compared to
Control Ischemic Hearts
Ischemia induces rapid intracellular acidification, and previous
experiments have demonstrated that acidosis reversibly inhibits
Ca2+ release through ryanodine receptors (RyR) (Xu et al., 1996;
Said et al., 2008). To assess the impact of β-AR inhibition on
SR Ca2+ release, direct optical mapping of free intra-SR Ca2+
was performed (Wang et al., 2014, 2015). Relative SR Ca2+
release amplitude (measured as systolic–diastolic fluorescence)
non-significantly decreased over time throughout ischemia and
reperfusion in both the IZ and NI of control hearts and in the NI
of Prop-treated hearts (Figure 3). This time-dependent decrease
in amplitude is likely due to dye leak and/or extrusion from
the SR over time (relative SR Ca2+ transient amplitude falls
to ∼60–70% by 30 min in NI regions, Figure 3B, green lines).
In contrast, the SR Ca2+ release amplitude in the IZ of Prop-
treated hearts tended to increase at 2 min and was significantly
larger at 5 min ischemia compared to the IZ of untreated hearts
(Figure 3B).
Although previous reports have indicated significant changes
in SR Ca2+ load throughout ischemia and reperfusion (Valverde
et al., 2010), no significant differences in uncalibrated relative
SR Ca2+ content (measured as diastolic fluorescence) were
observed in any region or time point, regardless of treatment
(Figure 3C).
β-AR Inhibition Prevents Ischemia-Induced
Slowing of SR Ca2+ Reuptake
Ischemia and associated acidosis are known to inhibit SERCA
activity (DeSantiago, 2004). Our data agree with this, as a
significant increase in the time constant of SR Ca2+ reuptake
(tau) was observed in the IZ of control hearts, which was reversed
upon reperfusion (Figure 4). In non-ischemic conditions, β-AR
inhibition may also increase tau by inhibiting phosphorylation
of phospholamban (PLB). Under ischemic conditions, however,
β-AR inhibition prevented the increase in tau observed in non-
treated hearts (Figure 4). Consistent with these changes in SR
Ca2+ reuptake, ischemia also led to a significant prolongation of
the SR Ca2+ transient duration in the IZ of control hearts, but
not in Prop-treated hearts (Figure 5).
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FIGURE 2 | (A,B) Action potential duration (APD) maps at preischemia, 15 min ischemia, and 15 min reperfusion in a control (A) and Prop-treated heart (B). (C,D)
Example optical action potentials from the ischemic zone (IZ) at preischemia, 15 min ischemia, and 15 min reperfusion. (E,F) Summary data of percent change in
APD80 relative to preischemia (Time = 0 min) for control (E) and Prop-treated hearts (F). Mean ± SD. N = 4–9 [p < 0.05: * vs. NI; + vs. BZ; # vs. preischemia
(Time = 0 min); ‡ vs. IZ + Prop].
β-AR Inhibition Prevents Ischemia-Induced
APD and SR Ca2+ Alternans
Ischemia is known to potentiate arrhythmogenic APD and
Ca2+ alternans (Qian et al., 2001; Lakireddy et al., 2005).
Under non-ischemic conditions, we and others have shown
that β-AR stimulation tends to suppress alternans due to
acceleration of SR Ca2+ release and reuptake (Florea and Blatter,
2012; Wang et al., 2014; Tomek et al., 2017). However, the
combined effects of β-AR inhibition and ischemia on APD
and SR Ca2+ alternans have not been assessed. Alternans
was measured at PCLs of 300 and 250 ms at baseline, 15
min ischemia, and following 15 min reperfusion. Neither
PCL produced significant alternans at baseline (Figure 6).
At 15 min ischemia, however, both APD and SR Ca2+
alternans were significantly increased at a PCL of 250 ms in
untreated hearts. Prop pre-treatment prevented APD and SR
Ca2+ alternans at both PCLs during ischemia and reperfusion
(Figure 6).
DISCUSSION
Our results indicate that even when controlling for chronotropic
and inotropic effects (with continuous pacing and administration
of an excitation-contraction uncoupler, respectively), β-AR
inhibition during the acute phase of ischemia prevents APD
shortening, alters SR Ca2+ release and reuptake kinetics, and
prevents arrhythmogenic APD and SR Ca2+ alternans. Although
some of these findings might be expected based on the
known effects of β-AR inhibition and subsequent inhibition
of protein kinase A (PKA) activation, other results are novel
and suggest a multifaceted role for β-AR inhibition during
ischemia.
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FIGURE 3 | (A) Example SR Ca2+ traces from the ischemic zone (IZ) during ischemia and reperfusion in a control and Prop-treated heart. (B) Summary data of
percent change in SR Ca2+ transient amplitude (systolic – diastolic fluorescence) relative to preischemia (Time = 0 min) for the non-ischemic (NI) and IZ of control and
Prop-treated hearts. A time-controlled sham heart (no ischemia) is shown for comparison. By 5 min ischemia, a significantly larger SR Ca2+ transient amplitude is
observed in the IZ of Prop-treated hearts vs. IZ of untreated hearts. Mean ± SD. N = 3–6 (p < 0.05: ‡ vs. IZ). (C) Summary data of percent change in diastolic SR
Ca2+ fluorescence (reflective of relative changes in SR Ca2+ content) for the NI and IZ of control and Prop-treated hearts as well as a time-controlled sham heart for
comparison.
Myocyte Responses to Ischemia
Ischemia results in intracellular acidification and activation of
the Na+/H+ exchanger, leading to an increase in intracellular
Na+. This Na+ overload results in intracellular Ca2+ overload
via reverse-mode Na+-Ca2+ exchanger (NCX) activity. At the
same time, SR Ca2+ release is dramatically reduced due to
inhibition of RyR by intracellular acidification and SERCA
function is inhibited due to both acidification and a reduction
in cellular ATP availability (Rapundalo et al., 1986; Xu et al.,
1996; DeSantiago, 2004; Said et al., 2008). Despite inhibition of
SR Ca2+ release and reuptake, previous studies have shown that
intracellular and SR Ca2+ levels remain high, but the amplitude
and speed of intracellular Ca2+ transients are significantly
reduced (Valverde et al., 2010) or even eliminated entirely with
severe ischemia or anoxia (Stern et al., 1988). Decreases in cellular
ATP levels may also lead to the opening of KATP channels,
which are thought to contribute to shortening of the APD during
ischemia (Weiss et al., 1992; Aon et al., 2003).
Neuronal Responses to Ischemia and
Local NE Release
As in myocytes, cardiac neurons also experience intracellular
acidification during ischemia, leading to activation of the
Na+/H+ exchanger and increased intracellular Na+. Under non-
ischemic conditions, the norepinephrine transporter (NET) is
responsible for the reuptake of extracellular NE and DA back
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FIGURE 4 | (A) SERCA activity was measured as the time constant (tau) of a
single exponential fit to the recovery portion of the SR Ca2+ transient.
Example trace from a control heart is in red and a Prop-treated heart is shown
in gray. Dashed lines indicate exponential fit. (B) Tau is significantly increased
in the IZ of control hearts at 15 min ischemia, whereas no change in tau is
observed in Prop-treated hearts at any time point. Mean ± SD. N = 3–6 [p <
0.05: * vs. NI; + vs. BZ; # vs. preischemia (Time = 0 min); ‡ vs. IZ + Prop].
into the neuron. NE and DA uptake by NET is coupled to the
influx of Na+ and Cl− (at a ratio of 1:1:1). During ischemia, NET
operates in reverse-mode and transports Na+, NE, and DA out of
the cell. This non-exocytotic release mechanism can increase NE
in the extracellular space up to 1000-times the normal plasma NE
concentrations within 15 min of ischemia (Schömig et al., 1987;
Kurz et al., 1995). Therefore, the myocardial response to ischemia
is a combination of hypoxia, acidosis, and elevated adrenergic
stimulation.
Effects of β-AR Inhibition during Ischemia
If significantly elevated NE results in increased β-AR
stimulation during ischemia, one might expect that some
of the electrophysiological effects of β-AR signaling would
augment or exacerbate myocyte responses to ischemia, while
others would oppose the cellular effects of ischemia. For example,
during ischemia, the APD shortens primarily due to the opening
of KATP channels (Weiss et al., 1992; Aon et al., 2003). β-AR
stimulation also typically results in a shortening of the APD,
primarily due to increased IKs. Therefore, ischemia and elevated
NE may produce additive effects on APD shortening, and
inhibition of β-AR signaling during ischemia would be expected
to blunt APD shortening. Indeed, our results are consistent
with this interpretation, as APD shortening was significantly
diminished when ischemic hearts were pre-treated with Prop
(Figure 2). However, Prop pre-treatment not only blunted, but
almost completely abolished APD shortening, even at 15 min
of ischemia (Figure 2F), suggesting that β-AR inhibition may
either be preventing reductions in cellular ATP and subsequent
opening of KATP channels, or inducing ionic currents that are
perhaps counterbalancing IKATP. Although APD shortening
was prevented, refractoriness was not directly measured in the
present study and post-repolarization refractoriness occurs
during ischemia (Janse et al., 1985; Sutton et al., 2000; Coronel
et al., 2012). β-AR inhibition may impact the spatial dispersion
of refractoriness and recovery of excitability and these changes
likely do not mirror changes in APD. Thus, further studies
are needed to directly assess how Prop modifies ischemic
post-repolarization refractoriness.
Ischemia reduces the amplitude of SR Ca2+ release via
inhibition of RyR and slows the rate of SR Ca2+ reuptake via
reductions in SERCA activity (Rapundalo et al., 1986; Xu et al.,
1996; DeSantiago, 2004; Said et al., 2008). β-AR stimulation
has the opposite effect, increasing the amplitude of SR Ca2+
release and accelerating SR Ca2+ reuptake (Bers, 2002). Thus, we
hypothesized that β-AR inhibition during ischemia would further
slow SR Ca2+ cycling kinetics. Contrary to this hypothesis,
we observed significant improvements in SR Ca2+ handling
with β-AR inhibition, including an increase in the amplitude
of SR Ca2+ release at 5 min ischemia compared to the IZ of
untreated hearts (Figure 3), SERCA activity that was similar to
non-ischemic conditions (measured as the time constant, tau,
of SR Ca2+ reuptake, Figure 4), and the absence of prolonged
SR Ca2+ transient duration (Figure 5). The rabbit heart typically
displays positive Ca2+-Vm coupling, meaning that a large Ca2+
transient is typically associated with a longer APD (Wang
et al., 2014). It is therefore possible that the increased SR Ca2+
transient amplitude contributed to the longer APDs observed in
Prop-treated ischemic hearts (perhaps countering the effects of
IKATP). However, due to the bidirectional coupling between Ca2+
and Vm, it is difficult to ascertain the precise contribution of
intracellular Ca2+ to the observed changes in Vm (Shiferaw et al.,
2005).
The molecular mechanisms governing the functional
improvements in SR Ca2+ release and reuptake with β-AR
inhibition were not investigated in the present study and are
likely multifactorial. Indeed, both SR Ca2+ release and reuptake
are modulated by several factors, including levels of protein
expression and phosphorylation, ATP/ADP, pH, and both
intracellular and intra-SR [Ca2+] and many of these variables
may be impacted by ischemia. The half-life of many Ca2+
handling proteins is quite long (e.g., up to 2–3 days for SERCA,
9+ h for PLB) (Andersson et al., 2009; Teng et al., 2015),
suggesting that significant changes in protein expression are
unlikely within 15 min of ischemia. Indeed, previous studies in
the adult rabbit heart indicated that SERCA mRNA levels were
decreased following 60 min ischemia, but protein expression
remained unchanged (Seehase et al., 2006).
Phosphorylation, on the other hand, is quite dynamic and
Vittone et al. (2002) reported maximal PKA phosphorylation
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FIGURE 5 | (A,B) Maps of SR Ca2+ transient duration at 80% recovery at preischemia, 15 min ischemia, and 15 min reperfusion in a control (A) and Prop-treated
heart (B). (C,D) Example SR Ca2+ traces from the ischemic zone (IZ) at preischemia, 15 min ischemia, and 15 min reperfusion. (E,F) Summary data of percent change
in SR Ca2+ transient duration relative to preischemia for control (E) and Prop-treated hearts (F). Mean ± SD. N = 3–6 [p < 0.05: # vs. preischemia (Time = 0 min)].
of PLB at 20 min ischemia, even though ischemia is known
to cause reduced SERCA activity (Rapundalo et al., 1986;
Valverde et al., 2010). These results suggest that during
ischemia, phosphorylation levels of PLB are no longer a
major determinant of SERCA activity and that other factors
(e.g., ATP/ADP, pH, [Ca2+]) are predominating. Interestingly,
Vittone et al. also reported that PLB phosphorylation was
reduced with Prop pre-treatment prior to ischemia. SERCA
function was not directly assessed in that study, but contractile
performance was improved and ischemic contracture was
reduced. The authors did not discern the precise mechanisms
but speculated that β-AR inhibition may preserve cellular
levels of ATP during ischemia (Vittone et al., 2002). Our
results are consistent with this interpretation in that Prop
pre-treatment likely reduces phosphorylation levels of PLB, yet
SERCA function was improved compared to control ischemic
conditions (Figures 4, 5), suggesting that other factors, such as
ATP availability, may be responsible. Indeed, one of the first
steps in the β-AR signaling cascade is the conversion of ATP to
cAMP via adenylyl cyclase. Thus, by inhibiting β-AR signaling,
significant ATP may be conserved and remain available for other
cellular processes during ischemia.
Several previous studies have assessed the impact of
modulating β-AR signaling during ischemia. For example,
experiments in the isolated mouse heart indicate that
spontaneous ventricular arrhythmias are significantly increased
when exogenous β-AR agonists (NE and Epi) are added to the
perfusate (Stables and Curtis, 2009). Likewise, ischemia-induced
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FIGURE 6 | Maps and example traces (from designated areas indicated by * on the maps) showing SR Ca2+ alternans magnitude in a control (A–C) and Prop-treated
heart (D–F) at preischemia, 15 min ischemia, and 15 min reperfusion during constant pacing at a cycle length of 250 ms. Alternans magnitude is increased in the IZ of
control hearts at 15 min ischemia but not Prop-treated hearts. Summary data of SR Ca2+ alternans magnitude (G) and APD alternans magnitude (H) at pacing cycle
lengths of 300 ms (VP300) and 250 ms (VP250). Mean ± SD. N = 3–6 [p < 0.05: # vs. preischemia (Time = 0 min); ‡ vs. IZ + Prop; § vs. VP300].
arrhythmias can be reduced with prior chemical or surgical
sympathectomy (Ebert et al., 1970; Culling et al., 1984),
indicating an important role for local nerve-released NE in
ischemic arrhythmias. In agreement with the present study,
Prop administration immediately following coronary artery
ligation in open-chest canine hearts has been shown to prevent
APD shortening (Kupersmith et al., 1976) and β-AR blockers
have been shown to reduce infarct size, reduce arrhythmias,
and improve survival in both ischemic animal models and
MI patients (Norris et al., 1984; Hoque et al., 1993; López-
Sendón et al., 2004; Dehina et al., 2014). However, none of
these previous studies have controlled for chronotropic or
inotropic effects; meaning that increasing or decreasing β-AR
signaling had direct effects on heart rate and contractility,
and therefore, significant impact on energy demand during
ischemia.
STUDY LIMITATIONS
Optical mapping of free intra-SR Ca2+ with Fluo-5N is not
a ratiometric approach. Therefore, the optical signals are
uncalibrated and only represent relative changes in SR [Ca2+].
Fluo-5N fluorescence decreased over time regardless of ischemic
conditions or treatment. This may be due, in part, to dye leak
or extrusion from the SR and this time-dependent decrease in
signal may obscure more subtle changes in SR Ca2+ load during
ischemia and reperfusion. Indeed, Valverde et al. (2010) reported
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a significant increase in SR Ca2+ load during ischemia in the
mouse heart, whereas no significant differences in relative SR
Ca2+ diastolic fluorescence (reflective of SR [Ca2+] load) were
observed under any condition in the present study. Prop is a non-
specific β-AR blocker. Therefore, the contribution of β1 vs. β2
receptor signaling was not assessed in the present study, but this
would be an important area for future work. Prop may also have
off-target membrane effects that are not fully accounted for and
these effectsmay differ during ischemia. Finally, the present study
did not fully dissect the primary effects of Prop during ischemia
from the inhibition of excessive β-AR stimulation that may
occur (due to local NE release). Experiments in fully denervated
or catecholamine-depleted hearts would allow for isolating any
potential primary effects of Prop from ischemia-released NE.
CONCLUSIONS
To our knowledge, this is the first study to control for
chronotropic and inotropic effects and evaluate the direct impact
of β-AR inhibition on action potential and Ca2+ handling
characteristics during ischemia. Here we report that even when
controlling heart rate and contractility, β-AR inhibition during
the acute phase of ischemia prevents APD shortening, alters
SR Ca2+ handling, and prevents arrhythmogenic APD and SR
Ca2+ alternans. These data are consistent with improved energy
metabolism with β-AR inhibition during ischemia. Investigation
into the cellular and molecular mechanisms responsible for these
effects remains an important area for future study.
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